Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A21188 | 25492997 | World J Gastroenterol | Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet. | 2014 | Details |
| A21189 | 25492996 | World J Gastroenterol | Non-invasive diagnosis of advanced fibrosis and cirrhosis. | 2014 | Details |
| A21190 | 25492154 | Zhonghua Liu Xing Bing Xue Za Zhi | [Relations between nonalcoholic fatty liver disease and metabolic syndrome]. | 2014 | Details |
| A21191 | 25491010 | Eur J Intern Med | The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis. | 2014 | Details |
| A21192 | 25489444 | Int J Prev Med | Effect of Vitamin D Supplementation on C-reactive Protein in Patients with Nonalcoholic Fatty Liver. | 2014 | Details |
| A21193 | 25488932 | Drug Metab Dispos | Renal xenobiotic transporter expression is altered in multiple experimental models of nonalcoholic steatohepatitis. | 2014 | Details |
| A21194 | 25486027 | Eur J Gastroenterol Hepatol | Comparison of noninvasive scores for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A21195 | 25486007 | PLoS One | A vaccine targeted at CETP alleviates high fat and high cholesterol diet-induced atherosclerosis and non-alcoholic steatohepatitis in rabbit. | 2014 | Details |
| A21196 | 25485911 | Nat Med | Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis. | 2014 | Details |
| A21197 | 25484079 | Autophagy | Calcium channel blockers as potential therapeutics for obesity-associated autophagy defects and fatty liver pathologies. | 2014 | Details |
| A21198 | 25484077 | Autophagy | Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway. | 2015 | Details |
| A21200 | 25482832 | Hepatology | Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). | 2015 | Details |
| A21203 | 25481429 | Lipids Health Dis | Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients. | 2014 | Details |
| A21204 | 25480592 | J Huazhong Univ Sci Technolog Med Sci | Assessment of fibrosis during the development of fatty liver in rabbits using real-time shear-wave elastography. | 2014 | Details |
| A21205 | 25479248 | Nutrients | The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease. | 2014 | Details |
| A21206 | 25479140 | Gastroenterology | Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer. | 2014 | Details |
| A21207 | 25479138 | Gastroenterology | Truncating mutation in the nitric oxide synthase 1 gene is associated with infantile achalasia. | 2014 | Details |
| A21208 | 25479137 | Gastroenterology | Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis. | 2014 | Details |
| A21209 | 25478922 | Clin Gastroenterol Hepatol | Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique. | 2014 | Details |
| A21211 | 25477977 | Hepat Mon | Apolipoprotein c3 gene polymorphisms are not a risk factor for developing non-alcoholic Fatty liver disease: a meta-analysis. | 2014 | Details |
| A21212 | 25477509 | J Biol Chem | Adipocyte-specific disruption of fat-specific protein 27 causes hepatosteatosis and insulin resistance in high-fat diet-fed mice. | 2014 | Details |
| A21213 | 25477264 | J Hepatol | Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. | 2014 | Details |
| A21214 | 25476828 | Life Sci | Chronic intermittent hypobaric hypoxia ameliorates endoplasmic reticulum stress mediated liver damage induced by fructose in rats. | 2014 | Details |
| A21215 | 25475859 | Hepatobiliary Pancreat Dis Int | New insight of vitamin D in chronic liver diseases. | 2014 | Details |
| A21216 | 25474087 | Int J Mol Sci | Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease. | 2014 | Details |
| A21217 | 25473159 | World J Gastroenterol | Gut microbiota and metabolic syndrome. | 2014 | Details |
| A21218 | 25470667 | Expert Opin Ther Pat | Acyltransferase inhibitors: a patent review (2010-present). | 2014 | Details |
| A21219 | 25470627 | Diabetes Metab Syndr | The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children. | 2013 | Details |
| A21220 | 25470250 | PLoS One | Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease. | 2014 | Details |
| A21221 | 25470242 | PLoS One | Neurotropin suppresses inflammatory cytokine expression and cell death through suppression of NF-κB and JNK in hepatocytes. | 2014 | Details |
| A21222 | 25469977 | J Gastroenterol Hepatol | Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals. | 2015 | Details |
| A21223 | 25469790 | J Gastroenterol Hepatol | Anti-adipocyte antibody response in patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A21225 | 25469068 | J Korean Med Sci | Comparison between a pediatric health promotion center and a pediatric obesity clinic in detecting metabolic syndrome and non-alcoholic fatty liver disease in children. | 2014 | Details |
| A21226 | 25469019 | World J Gastroenterol | Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications. | 2014 | Details |
| A21227 | 25469015 | World J Gastroenterol | Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis? | 2014 | Details |
| A21228 | 25469014 | World J Gastroenterol | Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development. | 2014 | Details |
| A21229 | 25469013 | World J Gastroenterol | Obesity, fatty liver disease and intestinal microbiota. | 2014 | Details |
| A21230 | 25468829 | Int J Obes (Lond) | Fetuin-A: a novel link between obesity and related complications. | 2014 | Details |
| A21231 | 25468788 | Med Hypotheses | Pentoxifylline in the management of metabolic syndrome and chronic hepatitis C. | 2014 | Details |
| A21232 | 25468486 | Transl Res | Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population. | 2014 | Details |
| A21235 | 25468160 | Lancet | Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. | 2014 | Details |
| A21236 | 25463079 | Atherosclerosis | Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness. | 2014 | Details |
| A21237 | 25462563 | Biochem Biophys Res Commun | The flavonoid monoHER promotes the adaption to oxidative stress during the onset of NAFLD. | 2014 | Details |
| A21238 | 25462066 | Redox Biol | The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts. | 2014 | Details |
| A21239 | 25461851 | Gastroenterology | Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. | 2014 | Details |
| A21240 | 25460293 | Horm Mol Biol Clin Investig | Nutrition: a promising route for prevention and management of obesity-related nonalcoholic fatty liver disease. | 2014 | Details |
| A21241 | 25460228 | Curr Opin Pharmacol | Transgenerational effects of obesogens and the obesity epidemic. | 2014 | Details |
| A21242 | 25460019 | Clin Gastroenterol Hepatol | Inflammation, psychiatric symptoms, and opioid use are associated with pain and disability in patients with cirrhosis. | 2014 | Details |
| A21243 | 25459558 | Clin Gastroenterol Hepatol | Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants. | 2014 | Details |
| A21244 | 25458829 | Metabolism | The addition of medium-chain triglycerides to a purified fish oil-based diet alters inflammatory profiles in mice. | 2014 | Details |
| A21245 | 25457209 | J Hepatol | Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2. | 2014 | Details |
| A21246 | 25457203 | J Hepatol | S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease. | 2014 | Details |
| A21247 | 25456868 | Am J Cardiol | Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk. | 2014 | Details |
| A21248 | 25456789 | Med Hypotheses | Nonalcoholic fatty liver disease (NAFLD)--is it a new marker of hyporesponsiveness to recombinant human erythropoietin in patients that are on chronic hemodialysis? | 2014 | Details |
| A21249 | 25456154 | Nutr Metab Cardiovasc Dis | Non-alcoholic fatty liver disease is associated with progression of arterial stiffness. | 2014 | Details |
| A21250 | 25456097 | Metabolism | Leptin in nonalcoholic fatty liver disease: a narrative review. | 2014 | Details |
| A21252 | 25454300 | Clin Liver Dis | Contemporary assessment of hepatic fibrosis. | 2014 | Details |
| A21253 | 25454294 | Clin Liver Dis | Chronic liver disease in the human immunodeficiency virus patient. | 2014 | Details |
| A21254 | 25453980 | Peptides | The role of renin-angiotensin system modulation on treatment and prevention of liver diseases. | 2014 | Details |
| A21255 | 25453513 | J Med Food | Green Tea Lowers Hepatic COX-2 and Prostaglandin E2 in Rats with Dietary Fat-Induced Nonalcoholic Steatohepatitis. | 2014 | Details |
| A21256 | 25452862 | BMJ Open Diabetes Res Care | Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease. | 2014 | Details |
| A21257 | 25451254 | Biochem Biophys Res Commun | Apolipoprotein A-I expression suppresses COX-2 expression by reducing reactive oxygen species in hepatocytes. | 2014 | Details |
| A21258 | 25451038 | Obesity (Silver Spring) | A dietary phytochemical blend prevents liver damage associated with adipose tissue mobilization in ovariectomized rats. | 2014 | Details |
| A21259 | 25450719 | J Hepatol | Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine. | 2014 | Details |
| A21260 | 25450718 | J Hepatol | Bioinformatics and database resources in hepatology. | 2014 | Details |
| A21262 | 25450583 | Arch Med Res | Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress. | 2014 | Details |
| A21263 | 25450212 | J Hepatol | Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity. | 2014 | Details |
| A21264 | 25450203 | J Hepatol | Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. | 2014 | Details |
| A21265 | 25450180 | Biochim Biophys Acta | Astaxanthin prevents TGFβ1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells. | 2014 | Details |
| A21266 | 25447969 | Wien Klin Wochenschr | Liver fatty acid-binding protein as a diagnostic marker for non-alcoholic fatty liver disease. | 2014 | Details |
| A21267 | 25446569 | Eur J Pharmacol | Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway. | 2014 | Details |
| A21268 | 25445436 | Life Sci | Beneficial effects of phosphatidylcholine on high-fat diet-induced obesity, hyperlipidemia and fatty liver in mice. | 2014 | Details |
| A21269 | 25445398 | J Hepatol | TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess. | 2014 | Details |
| A21270 | 25445395 | J Hepatol | Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease. | 2014 | Details |
| A21271 | 25445207 | Transl Res | Soluble urokinase plasminogen activator receptor levels are associated with severity of fibrosis in nonalcoholic fatty liver disease. | 2014 | Details |
| A21272 | 25443620 | Liver Int | The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation. | 2015 | Details |
| A21273 | 25443068 | Surg Obes Relat Dis | Prevalence and characteristics of individuals without diabetes and hypertension who underwent bariatric surgery: lessons learned about metabolically healthy obese. | 2014 | Details |
| A21274 | 25440222 | J Nutr Biochem | Pathophysiological basis for compromised health beyond generations: role of maternal high-fat diet and low-grade chronic inflammation. | 2014 | Details |
| A21275 | 25438866 | Liver Int | Light alcohol consumption plays a protective role against non-alcoholic fatty liver disease in Japanese men with metabolic syndrome. | 2015 | Details |
| A21276 | 25438524 | Wei Sheng Yan Jiu | [Interaction of polymorphisms of Leptin receptor gene Gln223Arg, MnSOD9Ala/Val genes and smoking in nonalcoholic fatty liver disease]. | 2014 | Details |
| A21278 | 25436123 | J Gastrointest Oncol | Association between nonalcoholic fatty liver disease and colorectal adenoma: a systemic review and meta-analysis. | 2014 | Details |
| A21279 | 25436098 | Gastroenterol Hepatol Bed Bench | Effect of non-alcoholic fatty liver disease on carotid artery intima-media thickness as a risk factor for atherosclerosis. | 2014 | Details |
| A21280 | 25433921 | Dig Dis Sci | Fibromyalgia symptoms and cirrhosis. | 2014 | Details |
| A21281 | 34860874 | J Pharm Technol | Past, Present, and Future Research Avenues for Metformin: A Literature Review. | 2014 | Details |
| A21282 | 28664097 | Integr Med Res | Practical approaches to the nutritional management of nonalcoholic fatty liver disease. | 2014 | Details |
| A21283 | 27356367 | Bull Acad Natl Med | [Metabolic syndrome, non alcoholic hepatic steatopathy and hepatocellular carcinoma: so dangerous liaisons]. | 2014 | Details |
| A21284 | 27356366 | Bull Acad Natl Med | [Not Available]. | 2014 | Details |
| A21285 | 25433160 | J Hepatol | Roles of alcohol consumption in fatty liver: a longitudinal study. | 2014 | Details |
| A21286 | 25433159 | J Hepatol | The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease. | 2014 | Details |
| A21287 | 25433106 | Nutr Hosp | Vitamin D levels and bone turnover markers are not related to non-alcoholic fatty liver disease in severely obese patients. | 2014 | Details |
| A21288 | 25430922 | Pharm Biol | A novel animal model of metabolic syndrome with non-alcoholic fatty liver disease and skin inflammation. | 2014 | Details |
| A21289 | 25430494 | J Clin Pathol | Canals of Hering loss relates to the progression of the histological stages of primary biliary cirrhosis. | 2014 | Details |
| A21290 | 25429984 | Hepatol Res | Serum alanine aminotransferase predicts the histological course of non-alcoholic steatohepatitis in Japanese patients. | 2014 | Details |
| A21291 | 25429853 | Aliment Pharmacol Ther | NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels. | 2014 | Details |
| A21292 | 25429378 | Scand J Gastroenterol | Noninvasive characterization of graft steatosis after liver transplantation. | 2014 | Details |
| A21293 | 25429318 | World J Hepatol | Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease. | 2014 | Details |
| A21294 | 25428903 | Am J Physiol Gastrointest Liver Physiol | Mosapride citrate improves nonalcoholic steatohepatitis with increased fecal lactic acid bacteria and plasma glucagon-like peptide-1 level in a rodent model. | 2014 | Details |
| A21295 | 25427907 | Adv Exp Med Biol | Understanding the tumor suppressor PTEN in chronic alcoholism and hepatocellular carcinoma. | 2015 | Details |
| A21296 | 25427901 | Adv Exp Med Biol | Alcohol and cancer: an overview with special emphasis on the role of acetaldehyde and cytochrome P450 2E1. | 2015 | Details |
| A21297 | 25427048 | J Cardiovasc Med (Hagerstown) | Inflammatory bowel disease, liver diseases and endothelial function: is there a linkage? | 2015 | Details |